Related Experiment Video
Updated: May 7, 2026
10:04
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
14.3K
Management of elderly patients with diffuse large B-cell lymphomas
Rosanna Ciancia1, Umberto Tirelli, Josep- Maria Ribera
1Division of Medical Oncology A, National Cancer Institute of Aviano, Via Franco Gallini 2, 33081 Aviano (PN), Italy. mspina@cro.it.
Anti-Cancer Agents in Medicinal Chemistry
|October 10, 2013
Summary
The growing elderly population requires tailored treatments for non-Hodgkin lymphoma (NHL). Comprehensive geriatric assessments can help manage treatment challenges in older adults with lymphoma.
Area of Science:
- Geriatric Medicine
- Oncology
- Hematology
Background:
- Global life expectancy has risen, leading to a rapidly expanding elderly population, particularly those over 80.
- The population aged over 75 is projected to triple by 2030, increasing the prevalence of age-related health issues.
- Non-Hodgkin lymphoma (NHL) management in geriatric patients presents unique challenges due to comorbidities and age-related physiological changes.
Purpose of the Study:
- To highlight the need for specialized treatment strategies for NHL in the elderly.
- To address the difficulties in managing lymphoma in older adults with multiple health conditions.
- To propose comprehensive geriatric assessment as a tool to facilitate clinical trials in this demographic.
Main Methods:
- Review of current trends in geriatric population growth.
- Analysis of challenges in treating elderly patients with lymphoma.
- Discussion of the potential utility of geriatric assessment tools.
Main Results:
- Elderly patients often have comorbidities that complicate lymphoma treatment.
- Standard high-dose therapies may be poorly tolerated by older adults, increasing toxicity risks.
- Prospective clinical trials in elderly lymphoma patients are difficult to conduct.
Conclusions:
- There is a critical need for developing and validating NHL treatment strategies specifically for geriatric patients.
- Comprehensive geriatric assessment may offer a viable approach to overcome challenges in conducting clinical trials for elderly lymphoma patients.
- Personalized treatment plans considering comorbidities and physiological changes are essential for effective NHL management in the elderly.
Related Concept Videos
02:56Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
01:15Drug Dosing: Geriatric Patients
402
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
402
01:24Nephrotic Syndrome III : Nursing Management
561
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
561